関連する実験動画
Updated: May 6, 2026
01:20
Renal Corpuscle
6.9K
長い非コーディングRNA CPR (心筋細胞増殖調節体) 心筋細胞増殖と心臓修復を調節する
Murugavel Ponnusamy1, Fang Liu2, Yu-Hui Zhang3
1Center for Developmental Cardiology, Institute for Translational Medicine, College of Medicine, Qingdao University, China (M.P., L.-Y.Z., C.-Y.L., K.-W.L., Y.-H.D., M.W., L.-L.Q., C.S., S.X., Q.W., Yan-Hui Zhang, P.-F.L., K.W.).
Circulation
|March 6, 2019
まとめ
心筋細胞増殖調節器 (CPR) は心臓細胞再生を抑制する. 心肺蘇生を抑制することで 心筋細胞の増殖と 心臓の損傷後の修復が促進され, 心不全の新たな治療戦略が提供されます.
科学分野:
- 心血管生物学
- 分子生物学
- エピジェネティクス
背景:
- 大人の心筋細胞は増殖能力を失い 心臓機能障害や心不全を引き起こします
- 衰弱した心筋細胞増殖の分子メカニズムはほとんど不明です.
- 長い非コーディングRNA (lncRNAs) は心血管疾患に作用し,心筋細胞の増殖と修復におけるその役割の調査を促した.
研究 の 目的:
- 心筋細胞の増殖と心臓の修復における lncRNA の役割を調査する.
- 心筋細胞の増殖に関与する 新種の lncRNA,CPRを特定し特徴づけること
主な方法:
- バイオインフォマティック分析で lncRNAを特定する
- 心臓特異性CPR過剰発現したマウスのCPRノックアウトの生成
- 隔離された心筋細胞をCPR静音化または過剰表現でインビトロ研究.
- 定量的なPCR,ウェスタンブラット,組織学,エコーカルディオグラフィ,トランスクリプトーム分析,RNAプルダウン,ChIPアッセイにより,心肺蘇生機能とメカニズムが解明される.
主要な成果:
- 成人の心臓は胎児の心臓よりも CPR レベルが高くなります
- CPRの静止は,産後および成人における心筋細胞増殖を増加させ,心筋損傷後の心臓機能を回復させた.
- 新生児の心筋細胞増殖と心臓再生を抑制した.
- CPRは,DNMT3AをMCM3プロモーターに誘導し,そのメチル化を減少させ,その発現を増加させることで,ミニクロモソームメンテナンス3 (MCM3) をターゲットにすることで,心筋細胞の増殖を抑制する.
結論:
- CPRは,心筋細胞増殖と心臓再生の負の調節剤として作用する.
- lncRNAは心筋細胞の増殖と心臓の修復に関与する.
- CPRは心臓の修復と再生のための lncRNAベースの潜在的な治療目標です.
関連する概念動画
Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Regulation of Heart Rates
6.2K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
6.2K
Cardiomyopathy I: Introduction and Classification
837
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Cardiomyopathy II: Dilated Cardiomyopathy
802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy IV: Restrictive Cardiomyopathy
968
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
968